PXD#

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 76 MGCD# [001] 72 AP# [003] 72 Phase Ib 71 elesclomol 70 CYT# 70 perifosine 70 Atiprimod 70 voreloxin 70 XL# [003] 69 INCB# [002] 69 ofatumumab 69 Perifosine 69 IMGN# 69 pralatrexate 68 pharmacodynamic 68 antitumor activity 68 RG# [001] 68 MDV# 67 vandetanib 67 HspE7 67 ISIS # 67 MGCD# [002] 67 hematologic malignancies 67 ASA# 67 preclinical studies 67 Phase 1b 67 kinase inhibitor 67 ZYBRESTAT 67 AZD# 67 tivozanib 66 carfilzomib 66 linaclotide 66 T DM1 66 LymphoStat B 66 Phase 2a 66 ENMD 66 hematological malignancies 66 anti angiogenic 66 Phase IIa trial 66 PLX# 65 bortezomib 65 ONCONASE 65 Marqibo 65 FOLOTYN 65 HRPC 65 TREANDA 65 HDAC inhibitors 65 RDEA# 65 sorafenib 65 gefitinib 65 CTCE 65 sunitinib 65 PRX # 65 CUDC 65 anticancer agents 64 chemotherapeutic agents 64 Phase 2b trial 64 eculizumab 64 daclizumab 64 Preclinical studies 64 Xcytrin 64 bavituximab 64 satraplatin 64 picoplatin 64 dose escalation 64 kinase inhibitors 64 solid tumors 64 taxanes 63 investigational compound 63 cutaneous T cell 63 ALN RSV# 63 tolerability 63 clofarabine 63 panitumumab 63 Zerenex 63 Phase 2b study 63 FTY# 63 DAVANAT ® 63 Phase 2a clinical 63 rituximab 63 brentuximab vedotin 63 pemetrexed 63 tolerability profile 63 laquinimod 63 vilazodone 63 dasatinib 63 Homspera 63 tamibarotene 63 ARRY 63 preclinical models 63 PF # [001] 63 ADVEXIN 63 preclinical 63 CRx 63 Phase 2b clinical 62 Phase IIa clinical 62 CBLB# 62 gemcitabine 62 Phase IIa 62 TroVax 62 antiviral activity

Back to home page